Extracorporeal membrane oxygenation (ECMO) has been used for> 40 years to support
lung and heart failure; however, bleeding and thrombosis remain serious complications. The …

Dabigatran etexilate is an oral, reversible direct thrombin inhibitor that is approved in the EU
and several other countries for the prevention of venous thromboembolism after elective hip …

The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is
charged with reviewing, updating and categorizating indications for therapeutic apheresis …

more often in cardiovascular surgical patients than in orthopedic surgical patients, in
postsurgical patients than in medical patients, in those treated with bovine heparin than …

Despite more than a half century of “safe” cardiopulmonary bypass (CPB), the evidence
base surrounding the conduct of anticoagulation therapy for CPB has not been organized …

The article evaluates risks associated with blood and blood component transfusion and the
optimal management of perioperative bleeding with cardiac surgery. The management of …

Despite more than a half century of “safe” cardiopulmonary bypass (CPB), the evidence
base surrounding the conduct of anticoagulation for CPB has not been organized into a …

Venous thromboembolism occurs commonly throughout the clinical course of patients with
brain tumors. A number of hemostatic and clinical factors contribute to this hypercoagulable …

Objective: Anticoagulation with heparin is standard of care for patients maintained on
extracorporeal life support. Very limited evidence exists for the use of alternative …

BACKGROUND: Heparin-induced thrombocytopenia (HIT) complicates the management of
patients presenting for cardiac surgery, because high-dose heparin anticoagulation for …